JP Stock MarketDetailed Quotes

4967 Kobayashi Pharmaceutical

Watchlist
  • 5658.0
  • -5.0-0.09%
20min DelayNot Open Jul 22 15:00 JST
441.61BMarket Cap21.10P/E (Static)

Kobayashi Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kobayashi Pharmaceutical Earnings Date

Currency: JPY

Period

Q1 FY2024 Earnings

May 10, 2024

Revenue(YoY)

36.49B

+9.02%
EPS(YoY)

13.13

-72.32%
Analyst Rating

Hold

Jul 1, 2024

Kobayashi Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 45.297B--
Aug 8, 20242024/Q2-- / 38.356B--
May 10, 20242024/Q136.485B / 36.358B--
Feb 9, 20242023/Q454.340B / 54.430B--
Nov 7, 20232023/Q345.490B / 45.027B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 45.297B--
Aug 8, 20242024/Q2-- / 38.356B--
May 10, 20242024/Q136.485B / 36.358B--
Feb 9, 20242023/Q454.340B / 54.430B--
Nov 7, 20232023/Q345.490B / 45.027B--

Unlock Free Earnings Estimates

Kobayashi Pharmaceutical Earnings Reports

  • Kobayashi Pharmaceutical: Confirmation letter

    May 15 02:00 ET

  • Kobayashi Pharmaceutical: Quarterly Report - First quarter of the 107th period (2024/01/01 to 2024/03/31)

    May 15 02:00 ET

  • Kobayashi Pharmaceutical: Extraordinary Report

    May 10 03:00 ET

  • Kobayashi Pharmaceutical: Notice regarding the recording of extraordinary losses and the withdrawal of full-year earnings forecasts

    May 10 02:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 1, 2024

    Hold

    • Strong Buy

      0.00%

    • Buy

      0.00%

    • Hold

      83.33%

    • Underperform

      0.00%

    • Sell

      16.67%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg